Hepatitis B Reactivation and Antiviral Prophylaxis in Patients on Immunosuppressive Therapy

Objectives: Hepatitis B virus reactivation (HBVr) may occur in patients receiving immunosuppressive therapy . The risk of HBVr varies depending on the immunosuppressive agent used and hepatitis serology . This study aimed to evaluate HBVr among immunosuppressed patients with and without antiviral prophylaxis. Materials and